These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1261 related items for PubMed ID: 10654013

  • 1. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant.
    Blau IW, Basara N, Bischoff M, Günzelmann S, Römer E, Kirsten D, Schmetzer B, Kiehl MG, Fauser AA.
    Bone Marrow Transplant; 2000 Jan; 25(1):41-5. PubMed ID: 10654013
    [Abstract] [Full Text] [Related]

  • 2. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY.
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [Abstract] [Full Text] [Related]

  • 3. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].
    Starý J, Kobylka P, Sedlácek P, Komrska V, Vávra V, Syrůcková Z, Smísek P, Hrubá A, Korínková P, Matĕjková E, Cukrová V, Dolezalová L, Loudová M, Sejkorová J, Kvĕch J.
    Cas Lek Cesk; 1998 Jun 15; 137(12):363-7. PubMed ID: 9721472
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
    Wang HH, Feng SZ, Wang M, Wei JL, Jiang EL, Zhang L, Huang Y, Zhou SY, Liu QG, Qiu LG, Han MZ, Yan WW.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul 15; 25(7):389-92. PubMed ID: 15355688
    [Abstract] [Full Text] [Related]

  • 5. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
    Sun J, Meng FY, Liu QF, Xu D, Xu B, Liu XL.
    Ai Zheng; 2003 Dec 15; 22(12):1321-4. PubMed ID: 14693060
    [Abstract] [Full Text] [Related]

  • 6. [Second allogeneic transplant for leukemia relapsed after first allogeneic transplantation].
    Yang DL, Han MZ, Feng SZ, Wang M, Zou DH, Wei JL, Yan ZS, Zhou SY, Liu QG, Jiang EL, Huang Y, Wang HH, Zhou Z, Zhai WJ, Yan WW, Han ZC.
    Zhonghua Xue Ye Xue Za Zhi; 2004 May 15; 25(5):285-9. PubMed ID: 15182537
    [Abstract] [Full Text] [Related]

  • 7. Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograft.
    di Grazia C, Raiola AM, Van Lint MT, Lamparelli T, Gualandi F, Berisso G, Bregante S, Dominietto A, Mordini N, Bruno B, Frassoni F, Bacigalupo A.
    Haematologica; 2001 Jun 15; 86(6):646-51. PubMed ID: 11418375
    [Abstract] [Full Text] [Related]

  • 8. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
    Kröger N, Zabelina T, Sonnenberg S, Krüger W, Renges H, Stute N, Finkenstein F, Mayer U, Holstein K, Fiedler W, Colberg H, Sonnen R, Kuse R, Braumann D, Metzner B, del Valle F, Erttmann R, Kabisch H, Zander AR.
    Bone Marrow Transplant; 2000 Oct 15; 26(7):711-6. PubMed ID: 11042650
    [Abstract] [Full Text] [Related]

  • 9. [Second allogeneic progenitor cell transplantation for leukemia relapse: results in 10 patients].
    Martínez C, Carreras E, Sierra J, Rovira M, Urbano-Ispizua A, Viguria MC, Vela D, Rozman C, Montserrat E.
    Med Clin (Barc); 1997 Oct 04; 109(11):401-5. PubMed ID: 9379728
    [Abstract] [Full Text] [Related]

  • 10. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
    Glass B, Majolino I, Dreger P, Scimè R, Santoro A, Vasta S, Suttorp M, Haferlach T, Schmitz N.
    Bone Marrow Transplant; 1997 Oct 04; 20(7):533-41. PubMed ID: 9337054
    [Abstract] [Full Text] [Related]

  • 11. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
    Kiehl MG, Kraut L, Schwerdtfeger R, Hertenstein B, Remberger M, Kroeger N, Stelljes M, Bornhaeuser M, Martin H, Scheid C, Ganser A, Zander AR, Kienast J, Ehninger G, Hoelzer D, Diehl V, Fauser AA, Ringden O.
    J Clin Oncol; 2004 Jul 15; 22(14):2816-25. PubMed ID: 15254049
    [Abstract] [Full Text] [Related]

  • 12. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.
    Haematologica; 2002 Jan 15; 87(1):52-8. PubMed ID: 11801465
    [Abstract] [Full Text] [Related]

  • 13. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T, Aisa Y, Watanabe R, Yamazaki R, Kato J, Shimizu T, Shigematsu N, Kubo A, Yajima T, Hibi T, Ikeda Y, Okamoto S.
    Biol Blood Marrow Transplant; 2008 Jun 15; 14(6):651-7. PubMed ID: 18489990
    [Abstract] [Full Text] [Related]

  • 14. Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant.
    Devine SM, Sanborn R, Jessop E, Stock W, Huml M, Peace D, Wickrema A, Yassine M, Amin K, Thomason D, Chen YH, Devine H, Maningo M, van Besien K.
    Bone Marrow Transplant; 2001 Sep 15; 28(6):557-62. PubMed ID: 11607768
    [Abstract] [Full Text] [Related]

  • 15. Effect of induced GVHD in leukemia patients relapsing after allogeneic bone marrow transplantation: single-center experience of 33 adult patients.
    Min CK, Eom KS, Lee S, Kim DW, Lee JW, Min WS, Kim CC.
    Bone Marrow Transplant; 2001 May 15; 27(9):999-1005. PubMed ID: 11436112
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Therapeutic efficacy of hematopoietic stem cell transplantation in patients with chronic myelogenous leukemia].
    Liu QF, Fan ZP, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov 15; 24(11):1227-9, 1241. PubMed ID: 15567763
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of relapse after allogeneic bone marrow transplantation with unmanipulated G-CSF-mobilized peripheral blood stem cell preparation.
    Siegert W, Beyer J, Kingreen D, Blasczyk R, Baurmann H, Schwella N, Schleicher J, Kirsch A, Huhn D.
    Bone Marrow Transplant; 1998 Sep 15; 22(6):579-83. PubMed ID: 9758347
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.